Literature DB >> 24837893

IMRT with capecitabine in advanced pancreatic cancer. In regard to Passoni et al.

Gang Ren1, Tingyi Xia1, Yingjie Wang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24837893     DOI： 10.1016/j.ijrobp.2014.02.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  2 in total

1.  Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy.

Authors:  Feng Teng; Lingling Meng; Fuhai Zhu; Gang Ren
Journal:  J Gastrointest Oncol       Date:  2021-04

2.  Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma.

Authors:  Xian Liu; Gang Ren; Liqin Li; Tingyi Xia
Journal:  Onco Targets Ther       Date:  2016-04-26       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.